Abstract
Licofelone (ML-3000), a dual inhibitor of 5-lipoxygenase and cyclooxygenase, reduces the level of cartilage chondrocyte death in vivo in experimental dog osteoarthritis: inhibition of pro-apoptotic factors.
Christelle Boileau, Johanne Martel-Pelletier, Jean-Yves Jouzeau, Patrick Netter, Florina Moldovan, Stefan Laufer, Susanne Tries and Jean-Pierre Pelletier
The Journal of Rheumatology July 2002, 29 (7) 1446-1453;
Christelle Boileau
Johanne Martel-Pelletier
Jean-Yves Jouzeau
Patrick Netter
Florina Moldovan
Stefan Laufer
Susanne Tries
In this issue
Licofelone (ML-3000), a dual inhibitor of 5-lipoxygenase and cyclooxygenase, reduces the level of cartilage chondrocyte death in vivo in experimental dog osteoarthritis: inhibition of pro-apoptotic factors.
Christelle Boileau, Johanne Martel-Pelletier, Jean-Yves Jouzeau, Patrick Netter, Florina Moldovan, Stefan Laufer, Susanne Tries, Jean-Pierre Pelletier
The Journal of Rheumatology Jul 2002, 29 (7) 1446-1453;
Licofelone (ML-3000), a dual inhibitor of 5-lipoxygenase and cyclooxygenase, reduces the level of cartilage chondrocyte death in vivo in experimental dog osteoarthritis: inhibition of pro-apoptotic factors.
Christelle Boileau, Johanne Martel-Pelletier, Jean-Yves Jouzeau, Patrick Netter, Florina Moldovan, Stefan Laufer, Susanne Tries, Jean-Pierre Pelletier
The Journal of Rheumatology Jul 2002, 29 (7) 1446-1453;